BREAKING — 25 PROVIDERS RANKED ACROSS 5 DESKS ◆ FILED FROM THE WATCHDESK ◆ VOL. I · NO. 05 · INDEPENDENT EDITORIAL · AD-FREE ◆ TIPS — INFO@POLICEFIRE.HEALTH ◆ NO PAID PLACEMENTS · NO SPONSORED RANKINGS ◆ BREAKING — 25 PROVIDERS RANKED ACROSS 5 DESKS ◆ FILED FROM THE WATCHDESK ◆ VOL. I · NO. 05 · INDEPENDENT EDITORIAL · AD-FREE ◆ TIPS — INFO@POLICEFIRE.HEALTH ◆ NO PAID PLACEMENTS · NO SPONSORED RANKINGS ◆
    FILED 11.16.26FIELD REPORT

    OCTOBER 28, 2026

    Galleri Coverage in 2026: Who Actually Pays the $949?


    Most health insurance plans still do not cover the Galleri multi-cancer early detection (MCED) test in 2026, and the list price is still $949. But you probably shouldn’t pay $949. Between TRICARE’s risk-based coverage, a growing list of fire departments buying the test outright for their members, state grant programs, and GRAIL’s own discounts, most first responders who want this test have at least one path to getting it for $599 or less — and in a lucky-but-growing number of departments, for free.

    Here at Badge Biohacking (policefire.health), we covered the science and the September advisory vote in our breakdown of the FDA panel’s endorsement of Galleri. This is the follow-up question everyone asked: who actually pays for it?

    Where the FDA process stands right now

    On September 23, 2026, an FDA advisory committee voted that Galleri is safe (10–0), effective (6–4), and that its benefits outweigh its risks for the proposed screening population (7–2, one abstention). The FDA usually follows its panels but isn’t required to, and as of this writing the agency has not issued a final approval decision. That matters for your wallet, because insurers have spent five years hiding behind one sentence — “this test is not FDA approved” — to justify non-coverage. Today Galleri is still sold as a laboratory-developed test, prescription-only. A formal approval would knock out the insurers’ favorite denial reason and start the clock on Medicare and commercial coverage decisions. It hasn’t happened yet.

    Does any insurance cover the Galleri test in 2026?

    A few payers do, and the biggest one matters to a lot of responders with military service: TRICARE. Under the current TriWest guidance, TRICARE covers Galleri for beneficiaries who are age 50 or older and have an elevated cancer risk — and the qualifying risk list explicitly includes service-related toxic exposures (burn pits, asbestos, Agent Orange), 20+ pack-years of smoking or vaping, two or more first-degree relatives with cancer, HIV, or a prior organ transplant. Pre-authorization through TriWest is required before the blood draw, with informed-consent documentation attached, and the published policy describes coverage as once per lifetime. If you’re a firefighter or officer who is also a military retiree over 50, this is likely your cheapest route — but get the pre-auth first, or you can end up owing the full price.

    Medicare does not cover Galleri. Most commercial plans don’t either, and GRAIL says so plainly on its own pricing page. A handful of employer wellness programs and life-insurance add-ons cover or subsidize it, so it’s worth one email to HR before you pay cash.

    The department route: free is becoming normal

    The most interesting shift since the FDA panel vote isn’t happening at insurance companies — it’s happening at city councils. Departments and cities that have run or funded Galleri (or similar MCED) screening programs for their firefighters now include Virginia Beach and Chesapeake in Virginia (where the state firefighters’ union is pushing the governor to fund annual screening statewide), Glendale, California (which covered screening for all 157 of its firefighters), Fishers, Indiana, Orange County, California (through a Hoag hospital partnership), and Allentown, Pennsylvania. Maryland went a step further: its legislature’s 2026 session produced bills (HB 1602/SB 579) requiring counties to offer no-cost cancer screening to volunteer and retired volunteer firefighters, backed by a state “innovative cancer screening” grant program funded at $900,000 for fiscal 2027.

    One number from Maryland’s fiscal analysis deserves attention: the average cost of the MCED blood test used in the state’s program was $245 per test in fiscal 2025. The note doesn’t name the test, and it may not be Galleri — but it tells you what screening costs when a government program negotiates volume pricing: roughly 74% below Galleri’s $949 retail list, by our math. If your department is pricing a program, that’s the benchmark to put in front of the vendor. Don’t accept retail-minus-10.

    What you’ll actually pay cash in 2026

    If you’re on your own, here’s the real math, verified as of October 28, 2026 from GRAIL’s published pricing:

    • List price: $949. Prescription required; some telehealth providers tack their visit fee on top.
    • Financial assistance: up to $350 off if your household income is at or below 400% of the federal poverty level, bringing the minimum out-of-pocket to $599.
    • First responder and military discount: GRAIL offers a discount verified through ID.me. The company doesn’t publish the amount — verify your status and get the number in writing before you order.
    • Payment plan: 0% interest for up to 12 months by phone, which works out to about $79 a month on the full list price.
    • FSA/HSA: generally eligible as pre-tax spending — confirm with your plan administrator.

    Where does Galleri fit in a bigger plan? It’s one tool, not the whole toolbox. It complements — never replaces — colonoscopy, skin checks, and the other age-based screenings in our firefighter cancer screening schedule, and if your concern is exposure tracking rather than detection, start with the PFAS blood test question first.

    Common Questions

    How much does the Galleri test cost without insurance in 2026?
    The list price is $949, verified as of October 28, 2026; financial assistance can reduce that to a minimum of $599, and GRAIL offers a 0% 12-month payment plan of roughly $79 a month.

    Does TRICARE cover the Galleri test?
    Yes, for beneficiaries 50 and older with an elevated cancer risk such as service-related toxic exposure or heavy smoking history, with TriWest pre-authorization required before the test is ordered.

    Is Galleri FDA approved yet?
    No. An FDA advisory panel voted in favor of approval on September 23, 2026, but the agency has not issued a final decision, so Galleri is still sold as a laboratory-developed test.

    Can my fire department pay for Galleri screening?
    Yes — cities including Glendale, Virginia Beach, Fishers, and Allentown have funded firefighter MCED screening, and government programs have negotiated per-test prices far below the $949 retail list.

    Will insurance cover Galleri after FDA approval?
    Not automatically. Approval would remove insurers’ main denial rationale and trigger Medicare and commercial coverage reviews, but each payer will still make its own coverage decision on its own timeline.

    Bottom line: if you want this test in 2026, don’t start by pulling out your credit card. Start by asking your department, your union, and (if you served) TRICARE — in that order. The responders getting Galleri for free didn’t get lucky. Someone in their department asked.

    This article is for informational purposes only and does not constitute medical advice. Badge Biohacking (policefire.health) is a comparison and review site. We may earn affiliate commissions from links on this site. Pricing and coverage details verified as of October 28, 2026, and subject to change. Always consult a qualified healthcare provider before starting any treatment or screening program.


    ← BACK TO FIELD REPORTS

    Medically reviewed by Dr. Ahmet Azak, MD. Reviewed Date: 05/10/2025. Police Officer & Firefighter Wellness is an independent telehealth review platform for police officers, firefighters, EMS, paramedics, military service members, and veterans. We rank providers for TRT (testosterone replacement therapy), ED treatment (tadalafil, sildenafil, Trimix), GLP-1 weight loss medications (semaglutide, tirzepatide), peptide therapy (sermorelin, BPC-157, ipamorelin), NAD+ protocols, and longevity medicine. Our editorial methodology evaluates pricing transparency, discreet unbranded packaging, avoidance of insurance billing and Health Information Exchange (HIE) participation, LegitScript and FDA-registered sourcing, and compatibility with first responder shift schedules, drug testing requirements, and station culture. First responder health, tactical athlete performance, hormone optimization, and discreet telemedicine for civil servants and military personnel.